Research output per year
Research output per year
- 11 results
Search results
-
2022
ESMO Handbook of Targeted Therapies and Precision Oncology - Chapter 2 - Molecular Techniques in Precision Oncology. Oczko-Wojciechowska M, GIOVANNETTI E. (Editors: Iwona Lugowska, Sandra Misale, Raffaele Califano, John BAG Haanen) Published: September 2022 https://oncologypro.esmo.org/education-library/esmo-handbooks/targeted-therapies-and-precision-oncology
Giovannetti, E., 2022, ESMO Handbook of Targeted Therapies and Precision Oncology - Chapter 2.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
2021
Preclinical studies on nanocarrier-mediated delivery of radiosensitizing agents to brain and pancreatic cancer with a future projection to liver cancer
Sminia, P., Che, PP., Slotman, BJ. & Giovannetti, E., 2021, Nanotherapeutics for the Treatment of Hepatocellular Carcinoma. Mukherjee, B. (ed.). Singapore: Bentham Science Publishers Ltd, p. 316-332 19 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
2019
Modification of Drug Response in Cancer by MicroRNAs
Meijer, L. L., Puik, J. R., Vivaldi, C., Capula, M., Vasile, E., Kazemier, G. & Giovannetti, E., 1 Jan 2019, Therapies for Retinal Degeneration: Targeting Common Processes. Calin, G. A., Peplow, P. V., Martinez, B. & Esquela-Kerscher, A. (eds.). 69 ed. Royal Society of Chemistry, Vol. 2019-January. p. 416-451 36 p. (RSC Drug Discovery Series; vol. 2019-January, no. 69).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
Open Access1 Citation (Scopus) -
2018
Targeting the Hepatocyte Growth Factor Receptor to Overcome Resistance to Targeted Therapies
van der Steen, N., Garajova, I., Rolfo, C., Cavazzoni, A. & Giovannetti, E., 1 Jan 2018, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Elsevier, p. 25-60 (Targeting Cell Survival Pathways to Enhance Response to Chemotherapy).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
2017
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon
Giovannetti, E., 2017, Advances in Experimental Medicine and Biology Series. SpringerResearch output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
101 Citations (Scopus) -
Liquid Biopsies in Esophageal, Gastric and Pancreatic Cancers
Giovannetti, E., 2017, Current Clinical Pathology Series. Humana PressResearch output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
Pancreatic Cancer: Prevention, Detection and Treatment
Giovannetti, E., Peters, GJ., Maftouh, M. & Avan, A., 2017, Gastrointestinal Cancers: Prevention, Detection and Treatment..Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
2016
CYB5A (Cytochrome B5 Type A (microsomal)
Gomez, V. E., Avan, A., Peters, GJ. & Giovannetti, E., 2016, Atlas Genet Cytogenet Oncol Hematol.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Professional
-
Pancreatic cancer: Prevention, detection and treatment
Avan, A., Maftouh, M., Ghayour-Mobarhan, M., Peters, G. J. & Giovannetti, E., 1 Jan 2016, Gastrointestinal Cancers: Prevention, Detection and Treatment. NOVA Science publishers, Inc., Vol. 2. p. 125-142 18 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
-
2015
Pharmacology and Clinical Development of New Molecularly Targeted Agents
Giovannetti, E. & Galvani, E., 2015, Targeted Therapies for Solid Tumors. p. 9-29Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic
-
2013
MIR211 (microRNA 211)
Avan, A., Maftouh, M., Peters, G. J. & Giovannetti, E., 2013, Atlas Genet Cytogenet Oncol Haematol.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic